R&D | March 19, 2026
IIT Roorkee unveils cutting-edge molecular medicine facility
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
MYC, a master regulator of oncogenic transcription, drives multiple high-burden cancers but has long eluded direct pharmacologic control
The partnership aims to develop novel, selective small molecules targeting TDP-43 pathology
Collaboration aims to deliver rapid, lab-quality testing to communities worldwide – making precision health more accessible
Automated parallel capillary electrophoresis system simplifies protein analysis
The company has raised US$4.5 million in funding for its AI operating system
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
This partnership is in line with the strategic focus of DKSH Business Unit Technology to solidify its position as a leading integrated solutions provider for the scientific Instrumentation market
Subscribe To Our Newsletter & Stay Updated
